Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,753 | -1,143 | -4,835 | -3,768 | -2,902 |
| Depreciation Amortization | 74 | 39 | 176 | 135 | 90 |
| Income taxes - deferred | 188 | 122 | -109 | 92 | 144 |
| Accounts receivable | -427 | -470 | -230 | -221 | 375 |
| Accounts payable and accrued liabilities | 219 | 182 | -278 | -12 | 132 |
| Other Working Capital | 812 | -37 | 1,854 | 544 | 915 |
| Other Operating Activity | 329 | 395 | 1,024 | 680 | -200 |
| Operating Cash Flow | $-558 | $-912 | $-2,398 | $-2,550 | $-1,446 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31 | -5 | -2 | -20 | -19 |
| Investing Cash Flow | $-31 | $-5 | $-2 | $-20 | $-19 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 373 | N/A | N/A |
| Common Stock Issued | 2,322 | 755 | 1,784 | 1,441 | -5 |
| Other Financing Activity | -242 | -119 | -481 | -387 | -259 |
| Financing Cash Flow | $2,080 | $636 | $1,676 | $1,054 | $-264 |
| Exchange Rate Effect | -541 | -258 | 32 | 102 | 46 |
| Beginning Cash Position | 3,128 | 3,128 | 3,820 | 3,820 | 3,820 |
| End Cash Position | 4,078 | 2,589 | 3,128 | 2,406 | 2,137 |
| Net Cash Flow | $950 | $-539 | $-692 | $-1,414 | $-1,683 |
| Free Cash Flow | |||||
| Operating Cash Flow | -558 | -912 | -2,398 | -2,550 | -1,446 |
| Capital Expenditure | -31 | -5 | -2 | -20 | -19 |
| Free Cash Flow | -589 | -917 | -2,400 | -2,570 | -1,465 |